ATE216883T1 - Verwendung von 4-phenyl-3,6-dihydro-2h-pyridyl derivaten als nmda rezeptor subtyp blocker - Google Patents
Verwendung von 4-phenyl-3,6-dihydro-2h-pyridyl derivaten als nmda rezeptor subtyp blockerInfo
- Publication number
- ATE216883T1 ATE216883T1 AT97905107T AT97905107T ATE216883T1 AT E216883 T1 ATE216883 T1 AT E216883T1 AT 97905107 T AT97905107 T AT 97905107T AT 97905107 T AT97905107 T AT 97905107T AT E216883 T1 ATE216883 T1 AT E216883T1
- Authority
- AT
- Austria
- Prior art keywords
- nmda receptor
- receptor subtype
- hydrogen
- dihydro
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96103636 | 1996-03-08 | ||
PCT/EP1997/000951 WO1997032581A1 (en) | 1996-03-08 | 1997-02-27 | Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE216883T1 true ATE216883T1 (de) | 2002-05-15 |
Family
ID=8222541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97905107T ATE216883T1 (de) | 1996-03-08 | 1997-02-27 | Verwendung von 4-phenyl-3,6-dihydro-2h-pyridyl derivaten als nmda rezeptor subtyp blocker |
Country Status (15)
Country | Link |
---|---|
US (1) | US5962472A (de) |
EP (1) | EP0885004B1 (de) |
JP (1) | JP3248917B2 (de) |
KR (1) | KR100352358B1 (de) |
CN (1) | CN1131031C (de) |
AT (1) | ATE216883T1 (de) |
AU (1) | AU717140B2 (de) |
BR (1) | BR9708171A (de) |
CA (1) | CA2248134A1 (de) |
DE (1) | DE69712325T2 (de) |
DK (1) | DK0885004T3 (de) |
ES (1) | ES2174220T3 (de) |
PT (1) | PT885004E (de) |
TR (1) | TR199801774T2 (de) |
WO (1) | WO1997032581A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1674087A1 (de) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylaktische Verwendung von N-Methyl-D-Aspartat Rezeptor (NMDA) Antagonisten |
EP1436258A4 (de) * | 2001-03-08 | 2005-03-23 | Univ Emory | Ph-wert-abhängige nmda-rezeptorantagonisten |
US6951875B2 (en) * | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
WO2005051919A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Aminopyrazole derivatives as gsk-3 inhibitors |
EA201070077A1 (ru) * | 2007-06-29 | 2010-08-30 | Эмори Юниверсити | Антагонисты nmda-рецепторов с нейропротективным действием |
JP2011516417A (ja) * | 2008-03-27 | 2011-05-26 | エヴォテック・ノイロサイエンシーズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Nmdanr2b−サブタイプ選択的アンタゴニストを使用する障害の処置方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH506525A (de) * | 1968-12-24 | 1971-04-30 | Hoffmann La Roche | Verfahren zur Herstellung von aromatischen Äthern |
CH558354A (de) * | 1970-06-17 | 1975-01-31 | Hoffmann La Roche | Verfahren zur herstellung von aromatischen aethern. |
US3879405A (en) * | 1970-06-19 | 1975-04-22 | Hoffmann La Roche | Tetrahydropyridine derivatives |
CH547802A (de) * | 1970-06-19 | 1974-04-11 | Hoffmann La Roche | Verfahren zur herstellung von tetrahydropyridinderivaten. |
US5149817A (en) * | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
DE4325855A1 (de) * | 1993-08-02 | 1995-02-09 | Boehringer Ingelheim Kg | Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE4325885A1 (de) * | 1993-08-02 | 1995-02-09 | Basf Ag | Elektrolumineszierende Anordnung |
DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
US5698565A (en) * | 1995-06-09 | 1997-12-16 | Hoffmann-La Roche Inc. | Use of phenoxy-pyridine derivatives |
-
1997
- 1997-02-27 DK DK97905107T patent/DK0885004T3/da active
- 1997-02-27 TR TR1998/01774T patent/TR199801774T2/xx unknown
- 1997-02-27 BR BR9708171A patent/BR9708171A/pt not_active Application Discontinuation
- 1997-02-27 JP JP53141697A patent/JP3248917B2/ja not_active Expired - Fee Related
- 1997-02-27 EP EP97905107A patent/EP0885004B1/de not_active Expired - Lifetime
- 1997-02-27 WO PCT/EP1997/000951 patent/WO1997032581A1/en active IP Right Grant
- 1997-02-27 DE DE69712325T patent/DE69712325T2/de not_active Expired - Fee Related
- 1997-02-27 KR KR10-1998-0706936A patent/KR100352358B1/ko not_active IP Right Cessation
- 1997-02-27 PT PT97905107T patent/PT885004E/pt unknown
- 1997-02-27 CN CN97192889A patent/CN1131031C/zh not_active Expired - Fee Related
- 1997-02-27 CA CA002248134A patent/CA2248134A1/en not_active Abandoned
- 1997-02-27 ES ES97905107T patent/ES2174220T3/es not_active Expired - Lifetime
- 1997-02-27 AU AU18782/97A patent/AU717140B2/en not_active Ceased
- 1997-02-27 AT AT97905107T patent/ATE216883T1/de not_active IP Right Cessation
- 1997-03-07 US US08/813,523 patent/US5962472A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR100352358B1 (ko) | 2003-03-10 |
EP0885004B1 (de) | 2002-05-02 |
DE69712325D1 (de) | 2002-06-06 |
US5962472A (en) | 1999-10-05 |
DK0885004T3 (da) | 2002-08-19 |
TR199801774T2 (xx) | 1998-12-21 |
JP2000507542A (ja) | 2000-06-20 |
PT885004E (pt) | 2002-08-30 |
CN1131031C (zh) | 2003-12-17 |
WO1997032581A1 (en) | 1997-09-12 |
CN1213304A (zh) | 1999-04-07 |
AU1878297A (en) | 1997-09-22 |
CA2248134A1 (en) | 1997-09-12 |
AU717140B2 (en) | 2000-03-16 |
DE69712325T2 (de) | 2002-11-28 |
EP0885004A1 (de) | 1998-12-23 |
ES2174220T3 (es) | 2002-11-01 |
KR19990087505A (ko) | 1999-12-27 |
JP3248917B2 (ja) | 2002-01-21 |
BR9708171A (pt) | 1999-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700232A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
HUP0402236A2 (hu) | Heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
MX9705590A (es) | Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen. | |
ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
HUP0001192A2 (hu) | Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására | |
DK0533280T4 (da) | Ny medicinsk anvendelse af tachykininantagonister | |
NO954694L (no) | Doseringsform for antidepressiva | |
DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
DE69616480D1 (de) | Piperidinderivate als neurokininantagonisten | |
ES2176204T3 (es) | Antidepresivos que contienen un derivado de xantina. | |
TW336939B (en) | Lipopeptide derivatives, a process for their preparation and their use | |
JO2321B1 (en) | 4-phenyl-pyridine derivatives | |
WO1999024022A3 (en) | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors | |
IL119828A (en) | 6-(disubstituted amino)-2,4-¬(bis(hydroxyaryl)¾-1,3,5-triazine derivatives their preparation and cosmetic light-screening agents containing them | |
NO20001514L (no) | Vitronectin-reseptor-antagonist | |
ATE216883T1 (de) | Verwendung von 4-phenyl-3,6-dihydro-2h-pyridyl derivaten als nmda rezeptor subtyp blocker | |
ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
DE69412073D1 (de) | Xanthinderivate als adenosin-a1 rezeptor antagonisten | |
HUP0002929A2 (hu) | Tachikinin receptor antagonista hatású 2-acilamino-propán-aminok és az ezeket tartalmazó gyógyszerkészítmények | |
NO973241L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b | |
NO20023041L (no) | Fremgangsmåte for fremstilling av pyrazolopyridazinderivater | |
ES2162078T3 (es) | Compuestos terapeuticos. | |
YU61096A (sh) | Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije | |
NO992316L (no) | Benzensulfonamidderivater og legemidler inneholdende disse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |